IsoRay Balance Sheet | StatInvestor

Health Care & Life Sciences » Biotechnology | IsoRay Inc.

IsoRay Inc. | Balance Sheet

Fiscal year is July-June. All values USD Thousands.

2013

2014

2015

2016

2017

2018

Cash & Short Term Investments

2,899.90

17,683.00

14,589.30

12,386.10

8,971.00

3,425

Total Accounts Receivable

935.30

966.10

1,068.70

605.00

793.00

1,233

Inventories

405.60

359.70

404.00

334.40

323.00

494

Other Current Assets

202.90

206.00

263.60

303.70

204.00

294

Total Current Assets

4,443.70

19,214.90

16,325.50

13,629.20

10,291.00

5,446

Net Property, Plant & Equipment

1,684.30

1,017.90

574.80

576.70

1,054.00

1,311

Total Investments and Advances

181.10

5,582.60

5,288.00

3,154.80

181.00

181

Intangible Assets

215.20

223.80

198.50

150.50

230.00

198

Other Assets

531.10

510.10

616.40

590.60

513.00

319

Total Assets

7,055.40

26,549.30

23,003.30

18,101.90

12,269.00

7,455

Accounts Payable

432.60

574.90

498.30

610.60

630.00

Other Current Liabilities

360.30

579.10

593.90

482.70

476.00

Total Current Liabilities

792.90

1,153.90

1,092.20

1,093.30

1,106.00

Provision for Risks & Charges

866.60

947.80

580.50

561.00

Other Liabilities

896.20

573.00

181.00

27.00

Total Liabilities

1,689.10

2,593.50

2,221.00

1,700.80

1,667.00

Common Equity (Total)

5,366.20

23,955.70

20,782.20

16,401.00

10,602.00

Total Shareholders' Equity

5,366.20

23,955.80

20,782.20

16,401.10

10,602.00

Total Equity

5,366.20

23,955.80

20,782.20

16,401.10

10,602.00

Liabilities & Shareholders' Equity

7,055.40

26,549.30

23,003.30

18,101.90

12,269.00

Preferred Stock (Carrying Value)

0.10

About IsoRay

View Profile

Address	350 Hills Street Richland Washington 99354 United States
Employees	-
Website	http://www.isoray.com
Updated	07/08/2019
IsoRay, Inc. is a medical technology company. Though its subsidiary IsoRay Medical, Inc., it develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. Its product include Cesium-131 (Cs-131), a radioisotope for the treatment of prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma, and pancreatic cancer.